Your browser doesn't support javascript.
loading
IMP075 targeting ClpP for colon cancer therapy in vivo and in vitro.
Zhang, Jiangnan; Luo, Baozhu; Sui, Jing; Qiu, Zhiqiang; Huang, Jiasheng; Yang, Tao; Luo, Youfu.
Afiliación
  • Zhang J; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Luo B; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Sui J; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Qiu Z; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Huang J; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Yang T; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China; Institute of Immunology and Inflammation, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu 610041, China. Electronic a
  • Luo Y; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China. Electronic address: luo_youfu@scu.edu.cn.
Biochem Pharmacol ; 204: 115232, 2022 10.
Article en En | MEDLINE | ID: mdl-36030831

Texto completo: 1 Colección: 01-internacional Asunto principal: Péptido Hidrolasas / Neoplasias del Colon Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Biochem Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Asunto principal: Péptido Hidrolasas / Neoplasias del Colon Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Biochem Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: China